Michael Reardon
Latest contributions
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Valve choice - Shaping index procedures and lifetime patient management
22 May 2025 – From EuroPCR 2025
This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
TAVI hotline: long-term registry data
15 May 2024 – From EuroPCR 2024
This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...
Innovations in TMVR and Intrepid trial updates
14 May 2024 – From EuroPCR 2024
Tune in to this session for comprehensive updates on APOLLO and Intrepid TF, along with invaluable lessons gleaned. Discover insights on patient screening for Intrepid TMVR, and delve into clinical case reviews highlighting advancements such as updated 29Fr access. Learn about the safety and efficacy of...
Contemporary surgical & transcatheter treatment options for severe aortic regurgitation patients
05 Dec 2023 – From PCR London Valves 2023
Two cardiac surgeons, Hendrik Treede and Michael Reardon, and an echo specialist, Joao Cavalcante, have been invited to share their views on aortic regurgitation management.
So far, surgery remains the gold standard, and they explain why, by also comparing repair and replacement, before discussing the challenge that...
Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?
21 Nov 2023 – From PCR London Valves 2023
Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...
An intrepid solution for transfemoral treatment of mitral regurgitation
21 Nov 2023 – From PCR London Valves 2023
In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.
Aortic regurgitation - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to gain valuable knowledge on approaches to address aortic regurgitation: uncover the clinical effectiveness of TAVR in managing aortic insufficiency associated with LVAD and delve into the comparison between echocardiography and magnetic resonance imaging for assessing device regurgitation in patients undergoing TAVI.
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
Valve performance and durability - Main considerations in selecting the right TAVI valve
20 Nov 2023 – From PCR London Valves 2023
In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...
Remaining unmet needs and strategies in TAVI
19 Feb 2023 – From PCR Tokyo Valves 2023
This session focuses on valve design and durability performance in TAVI for patients with aortic stenosis, and the way it impacts future patient outcomes.
My worst nightmare in TAVI
Listen to our experts share their most nightmarish TAVI cases and follow the debate around their treatments. For instance, would you make the same choices when faced with a 76-year-old female patient diagnosed as severe AS, transferred for SAVR/TAVI, who got a new Abif and cardiogenic...
Predictability and control: Evolut procedural approaches
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into Evolut procedural approaches. You will be examining the cusp overlap technique, its latest clinical data and outcomes of the Medtronic's newest generational technology: Evolut FX.
TAVI with advanced imaging techniques - LIVE case
18 Feb 2023 – From PCR Tokyo Valves 2023
A 93-year-old female, with chronic kidney disease (GFR:34), diabetes, first degree AV block, present a symptomatic severe calcified aortic stenosis. Watch the operators as they implant an Evolut pro 26mm, guided by ICE in order to check the position of the distal part of the valve with...
Remaining unmet needs and strategies in TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.
Challenging scenarios: bicuspid aortic valves
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.
TAVI in complex situations - LIVE case
28 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI with the presence of a mechanical mitral valve.
An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
TAVI: Late-Breaking Trials and Innovations
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!
How should the clinical data on TAVI durability impact the clinical practice?
11 Mar 2021
View the replay of this PCR Webinar on TAVI with L. Sondergaard, D. Capodanno, M. Reardon.
How can I minimise paravalvular leak for my TAVI patients?
07 Jul 2021
Watch this PCR Webinar on TAVI with A. Latib, M. Reardon and L. Sondergaard.
Aortic valve disease: state-of-the-art
22 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session begins with important updates on the seminal trials that have defined our TAVI era over the past decade before moving on to new studies that are very likely to shape the evolution of TAVI in the next ten years.
#2 - How can I minimise paravalvular leak for my TAVI patients?
29 Jun 2021
Watch this PCR Webinar with A. Latib, M. Reardon and L. Sondergaard
Next-generation TAVR device will enable lifetime management of aortic stenosis patients
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance...
How should the clinical data on TAVI durability impact the clinical practice?
10 Mar 2021
Watch this PCR Webinar with L. Sondergaard, D. Capodanno, M. Reardon.
PCR e-Course Hot lines on TAVI – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.
TAVI: Full one-year Evolut low-risk randomised results and economic implications
EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications to understand the potential drivers for TAVI cost-effectives in Europe.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
Innovations in TAVI technique and technology to address evolving patient needs
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the innovations in TAVI technique and technology, adapting to the changing needs of younger and lower risk patients, and discover how to optimise TAVI procedural outcomes and minimise the need for permanent pacemaker implantation and how to use Evolut PRO+ valve...
Mitral anatomy and pathophysiology LIVE – An in-depth interactive workshop
17 Nov 2019 – From PCR London Valves 2019